| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.083 | 0.6 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.088 | 0.6 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.069 | 0.6 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |